Literature DB >> 15632175

Dual functionality of the anti-beta1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors.

Jonathan D Humphries1, Neil R Schofield, Zohreh Mostafavi-Pour, Linda J Green, Alistair N Garratt, A Paul Mould, Martin J Humphries.   

Abstract

Although integrins are known to mediate connections between extracellular adhesion molecules and the intracellular actin cytoskeleton, the mechanisms that are responsible for coupling ligand binding to intracellular signaling, for generating diversity in signaling, and for determining the efficacy of integrin signaling in response to ligand engagement are largely unknown. By characterizing the class of anti-integrin monoclonal antibodies (mAbs) that stimulate integrin activation and ligand binding, we have identified integrin-ligand-mAb complexes that exhibit differential signaling properties. Specifically, addition of 12G10 mAb to cells adhering via integrin alpha4beta1 was found to trigger disruption of the actin cytoskeleton and prevent cell attachment and spreading, whereas mAb addition to cells adhering via alpha5beta1 stimulated all of these processes. In contrast, soluble ligand binding to either alpha4beta1 or alpha5beta1 was augmented or unaffected by 12G10. The regions of the integrin responsible for differential signaling were then mapped using chimeras. Surprisingly, a chimeric alpha5 integrin containing the beta-propeller domain from the ligand binding pocket of alpha4 exhibited the same signaling properties as the full-length alpha4 integrin, whereas exchanging or removing cytoplasmic domains had no effect. Thus the mAb 12G10 demonstrates dual functionality, inhibiting cell adhesion and spreading while augmenting soluble ligand binding, via a mechanism that is determined by the extracellular beta-propeller domain of the associating alpha-subunit. These findings therefore demonstrate a direct and variable agonistic link between the ligand binding pocket of integrins and the cell interior that is independent of the alpha cytoplasmic domains. We propose that either ligand-specific transmembrane conformational changes or ligand-specific differences in the kinetics of transmembrane domain separation underlie integrin agonism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632175      PMCID: PMC3327468          DOI: 10.1074/jbc.M411102200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.

Authors:  Jian-Ping Xiong; Thilo Stehle; Rongguang Zhang; Andrzej Joachimiak; Matthias Frech; Simon L Goodman; M Amin Arnaout
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

Review 3.  Sensing the environment: a historical perspective on integrin signal transduction.

Authors:  Cindy K Miranti; Joan S Brugge
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

Review 4.  Integrin structure.

Authors:  M J Humphries
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

5.  Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling.

Authors:  Junichi Takagi; Benjamin M Petre; Thomas Walz; Timothy A Springer
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

6.  A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face.

Authors:  Olga Vinogradova; Algirdas Velyvis; Asta Velyviene; Bin Hu; Thomas Haas; Edward Plow; Jun Qin
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

7.  Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit.

Authors:  A P Mould; A N Garratt; J A Askari; S K Akiyama; M J Humphries
Journal:  FEBS Lett       Date:  1995-04-17       Impact factor: 4.124

8.  Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain.

Authors:  A Paul Mould; Janet A Askari; Stephanie Barton; Adam D Kline; Paul A McEwan; Susan E Craig; Martin J Humphries
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

9.  Positive regulation of cell-cell and cell-substrate adhesion by protein kinase A.

Authors:  J D Whittard; S K Akiyama
Journal:  J Cell Sci       Date:  2001-09       Impact factor: 5.285

10.  Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling.

Authors:  Hui Miao; Song Li; Ying-Li Hu; Suli Yuan; Yihua Zhao; Benjamin P C Chen; Wilma Puzon-McLaughlin; Takehiko Tarui; John Y-J Shyy; Yoshikazu Takada; Shunichi Usami; Shu Chien
Journal:  J Cell Sci       Date:  2002-05-15       Impact factor: 5.285

View more
  14 in total

Review 1.  Parsing the niche code: the molecular mechanisms governing hematopoietic stem cell adhesion and differentiation.

Authors:  E Camilla Forsberg; Stephanie Smith-Berdan
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

2.  RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.

Authors:  Dan Shan; Jason Li; Ping Cai; Preethy Prasad; Franky Liu; Andrew Michael Rauth; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

3.  Kindlin-1 and -2 have overlapping functions in epithelial cells implications for phenotype modification.

Authors:  Yinghong He; Philipp Esser; Anja Heinemann; Leena Bruckner-Tuderman; Cristina Has
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Heparin II domain of fibronectin mediates contractility through an alpha4beta1 co-signaling pathway.

Authors:  Marie K Schwinn; Jose M Gonzalez; B'Ann T Gabelt; Nader Sheibani; Paul L Kaufman; Donna M Peters
Journal:  Exp Cell Res       Date:  2010-03-17       Impact factor: 3.905

5.  Remanent cell traction force in renal vascular smooth muscle cells induced by integrin-mediated mechanotransduction.

Authors:  Lavanya Balasubramanian; Chun-Min Lo; James S K Sham; Kay-Pong Yip
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-16       Impact factor: 4.249

6.  Binding of extracellular maspin to beta1 integrins inhibits vascular smooth muscle cell migration.

Authors:  Rosemary Bass; Laura Wagstaff; Lorna Ravenhill; Vincent Ellis
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

7.  Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.

Authors:  Jonathan D Humphries; Adam Byron; Mark D Bass; Sue E Craig; John W Pinney; David Knight; Martin J Humphries
Journal:  Sci Signal       Date:  2009-09-08       Impact factor: 8.192

8.  β1 integrin NPXY motifs regulate kidney collecting-duct development and maintenance by induced-fit interactions with cytosolic proteins.

Authors:  Sijo Mathew; Zhenwei Lu; Riya J Palamuttam; Glenda Mernaugh; Arina Hadziselimovic; Jiang Chen; Nada Bulus; Leslie S Gewin; Markus Voehler; Alexander Meves; Christoph Ballestrem; Reinhard Fässler; Ambra Pozzi; Charles R Sanders; Roy Zent
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

9.  Distinct biophysical mechanisms of focal adhesion kinase mechanoactivation by different extracellular matrix proteins.

Authors:  Jihye Seong; Arash Tajik; Jie Sun; Jun-Lin Guan; Martin J Humphries; Susan E Craig; Asha Shekaran; Andrés J García; Shaoying Lu; Michael Z Lin; Ning Wang; Yingxiao Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

10.  Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.

Authors:  Adam Byron; Jonathan D Humphries; Sue E Craig; David Knight; Martin J Humphries
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.